US2007199898A1PendingUtilityA1

Dialysate of peritoneal dialysis and its preparation method

61
Assignee: SAKAI ASAHIPriority: Sep 13, 2000Filed: Feb 12, 2007Published: Aug 30, 2007
Est. expirySep 13, 2020(expired)· nominal 20-yr term from priority
A61K 9/08A61K 45/06A61M 1/287A61K 31/70
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An aqueous solution of electrolytes, a sugar osmotic agent and a physiologically safe salt of a reductive sulfur oxy-acid. Alternatively, the dialysate comprises an aqueous solution of electrolytes, a salt of a reductive sulfur oxy-acid, and osmotic agents which contain an oncotic agent other than a sugar osmotic agent.

Claims

exact text as granted — not AI-modified
1 - 16 . (canceled)  
     
     
         17 . A method for suppressing protein crosslinking in a patient during peritoneal dialysis using a dialysate, which comprises adding thiosulfate or dithionite to the dialysate.  
     
     
         18 . The method of  claim 17 , wherein the dialysate comprises an aqueous solution of electrolytes, a sugar osmotic agent and a physiologically safe salt of a reductive sulfur oxy-acid selected from thiosulfate or dithionite.  
     
     
         19 . The method of  claim 17 , wherein the dialysate comprises an aqueous solution of electrolytes, a salt of a reductive sulfur oxy-acid, and osmotic agents which contain an oncotic agent other than a sugar osmotic agent.  
     
     
         20 . The method of  claim 18 , which dialysate contains an oncotic agent other than a sugar osmotic agent.  
     
     
         21 . The method of  claim 19 , wherein the salt of the reductive sulfur oxy-acid is a physiologically safe salt of thiosulfate or dithionite.  
     
     
         22 . The method of  claim 18 , wherein the physiologically safe salt is sodium or potassium.  
     
     
         23 . The method of  claim 22 , wherein the physiologically safe salt is sodium or potassium.  
     
     
         24 . A method for conducting peritoneal dialysis on a patient in need thereof using a dialysate, which comprises conducting the peritoneal dialysis on the patient using the dialysate which includes a thiosulfate or dithionite.  
     
     
         25 . The method of  claim 24 , wherein the dialysate comprises an aqueous solution of electrolytes, a sugar osmotic agent and a physiologically safe salt of a reductive sulfur oxy-acid selected from thiosulfate or dithionite.  
     
     
         26 . The method of  claim 24 , wherein the dialysate comprises an aqueous solution of electrolytes, a salt of a reductive sulfur oxy-acid, and osmotic agents which contain an oncotic agent other than a sugar osmotic agent.  
     
     
         27 . The method of  claim 25 , which dialysate contains an oncotic agent other than a sugar osmotic agent.  
     
     
         28 . The method of  claim 26 , wherein the salt of the reductive sulfur oxy-acid is a physiologically safe salt of thiosulfate or dithionite.  
     
     
         29 . The method of  claim 25 , wherein the physiologically safe salt is sodium or potassium.  
     
     
         30 . The method of  claim 28 , wherein the physiologically safe salt is sodium or potassium.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.